ReviewInternational journal of nanomedicine2026
Nanocarrier-Enabled siRNA Therapy for Pulmonary Fibrosis: Pharmacological Rationale, Delivery Barriers, and Translational Opportunities.
Zhao-Qi Lv et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.